Good Clinical Practices (cGCP)
Core Concepts of RECIST 1.1
At the center of every oncology trial is a patient who relies on accurate scientific evaluation. This means that even a single millimeter on a scan or a transcription error can mean the difference between continuing a life-saving therapy and abandoning it prematurely. With differentiated content for Principal Investigators, Radiologists, and Site Staff, ELM-349 connects the rigorous mechanics of RECIST 1.1 with its human and strategic impact. The course illustrates how patients and the validity of global trial endpoints such as Progression-Free Survival (PFS) and Objective Response Rate (ORR) are both protected through the RECIST 1.1 framework.
Using hands-on, interactive scenarios built on clinical trial workflows, Learners will experience a role-based walkthrough of how the RECIST 1.1 criteria are applied across screening, longitudinal monitoring, and database lock. While investigators will focus on executive oversight, radiologists and Site Staff will master practical tasks, such as establishing the Sum of Diameters (SoD), auditing electronic Case Report Forms (eCRFs), and synthesizing multi-stream data into accurate timepoint response verdicts (Complete Response, Partial Response, Stable Disease, and Progressive Disease).
This applied approach takes complex criteria and transforms them into clear daily routines, ensuring Investigators can cogently direct RECIST 1.1 rules as site teams confidently execute protocol requirements and protect trial continuity.